Heat-Activated Target Therapy of Local-Regional Relapse in Breast Cancer Patients

Summary

The 105-15-201 study is designed to assess the effectiveness and tolerability of the combination of heat-activated target therapy (radiotherapy + hyperthermia + lyso-thermosensitive liposomal doxorubicin) of loco-regional relapse in breast cancer patients.

Timeline

Start

2017-03

Primary completion

2019-12

Completion

2020-02

Outcome

Outcome not reported

Stopped: “Administrative”

Drugs

Indications